Jan Westerink

5.4k total citations
131 papers, 2.7k citations indexed

About

Jan Westerink is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Jan Westerink has authored 131 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Cardiology and Cardiovascular Medicine, 51 papers in Endocrinology, Diabetes and Metabolism and 42 papers in Surgery. Recurrent topics in Jan Westerink's work include Lipoproteins and Cardiovascular Health (24 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (24 papers) and Diabetes Treatment and Management (20 papers). Jan Westerink is often cited by papers focused on Lipoproteins and Cardiovascular Health (24 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (24 papers) and Diabetes Treatment and Management (20 papers). Jan Westerink collaborates with scholars based in Netherlands, United Kingdom and United States. Jan Westerink's co-authors include Frank L.J. Visseren, Yolanda van der Graaf, Michiel L. Bots, Gert J. de Borst, Eelco J.P. de Koning, Harold W. de Valk, Maarten J. Cramer, L. Jaap Kappelle, Ton J. Rabelink and Hendrik M. Nathoe and has published in prestigious journals such as Circulation, Blood and Journal of the American College of Cardiology.

In The Last Decade

Jan Westerink

128 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jan Westerink Netherlands	27	966	784	766	497	315	131	2.7k
Roberta Lupoli Italy	32	594 0.6×	575 0.7×	866 1.1×	352 0.7×	212 0.7×	100	3.1k
Patrick R. Lawler Canada	34	1.4k 1.4×	590 0.8×	1.1k 1.4×	596 1.2×	274 0.9×	124	4.3k
Damiano Baldassarre Italy	28	1.5k 1.6×	687 0.9×	890 1.2×	405 0.8×	724 2.3×	95	3.1k
Felice Gragnano Italy	28	1.0k 1.1×	432 0.6×	644 0.8×	292 0.6×	167 0.5×	114	2.0k
Luis Afonso United States	28	2.1k 2.1×	393 0.5×	1.1k 1.5×	817 1.6×	425 1.3×	205	3.7k
Hüseyin Uyarel Türkiye	30	1.6k 1.7×	439 0.6×	614 0.8×	745 1.5×	410 1.3×	164	3.4k
Tanja B. Grammer Germany	36	906 0.9×	845 1.1×	936 1.2×	456 0.9×	246 0.8×	110	3.7k
Adriana M. Hung United States	30	473 0.5×	828 1.1×	605 0.8×	359 0.7×	312 1.0×	124	3.3k
Francesco Barillà Italy	25	1.5k 1.5×	281 0.4×	515 0.7×	234 0.5×	278 0.9×	152	2.4k
Leo F. Buckley United States	27	1.2k 1.3×	374 0.5×	536 0.7×	221 0.4×	224 0.7×	91	2.4k

Countries citing papers authored by Jan Westerink

Since Specialization

Citations

This map shows the geographic impact of Jan Westerink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Westerink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Westerink more than expected).

Fields of papers citing papers by Jan Westerink

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Westerink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Westerink. The network helps show where Jan Westerink may publish in the future.

Co-authorship network of co-authors of Jan Westerink

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Westerink. A scholar is included among the top collaborators of Jan Westerink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Westerink. Jan Westerink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hageman, Steven H J, Martin Teraa, Manon G. van der Meer, et al.. (2024). Generalisability of trials on antithrombotic treatment intensification in patients with cardiovascular disease. Heart. 110(7). heartjnl–2023. 2 indexed citations

Vries, Marieke de, et al.. (2024). Association of physical activity and sports participation with insulin resistance and non‐alcoholic fatty liver disease in people with type 1 diabetes. Diabetic Medicine. 41(7). e15317–e15317. 2 indexed citations

Hageman, Steven H J, Björn Eliasson, Naveed Sattar, et al.. (2024). Lifetime and 10‐year cardiovascular risk prediction in individuals with type 1 diabetes: The LIFE‐T1D model. Diabetes Obesity and Metabolism. 26(6). 2229–2238. 4 indexed citations

Vries, Marieke de, et al.. (2022). Non-alcoholic fatty liver disease: identical etiologic factors in patients with type 1 and type 2 diabetes. European Journal of Internal Medicine. 100. 77–82. 24 indexed citations

Vonk, Jet M. J., Yaakov Stern, Folkert W. Asselbergs, et al.. (2022). The role of cognitive and brain reserve in memory decline and atrophy rate in mid and late-life: The SMART-MR study. Cortex. 148. 204–214. 13 indexed citations

Hattum, E.S. van, Çağdaş Ünlü, Saskia Middeldorp, et al.. (2022). Post‐thrombotic syndrome after upper extremity deep vein thrombosis: An international Delphi consensus study. Journal of Thrombosis and Haemostasis. 20(8). 1880–1886. 7 indexed citations

Harlianto, Netanja I., Jan Westerink, Wouter Foppen, et al.. (2021). Visceral Adipose Tissue and Different Measures of Adiposity in Different Severities of Diffuse Idiopathic Skeletal Hyperostosis. Journal of Personalized Medicine. 11(7). 663–663. 14 indexed citations

Hendrikse, Jeroen, L. Jaap Kappelle, Mirjam I. Geerlings, et al.. (2021). Association of Ischemic Imaging Phenotype With Progression of Brain Atrophy and Cerebrovascular Lesions on MRI. Neurology. 97(11). e1063–e1074. 2 indexed citations

Vries, Marieke de, et al.. (2021). Insulin resistance and risk of vascular events, interventions and mortality in type 1 diabetes. European Journal of Endocrinology. 185(6). 831–840. 27 indexed citations

10.

Vries, Tamar I. de, Jan Westerink, Michiel L. Bots, et al.. (2021). Relationship between classic vascular risk factors and cumulative recurrent cardiovascular event burden in patients with clinically manifest vascular disease: results from the UCC-SMART prospective cohort study. BMJ Open. 11(3). e038881–e038881. 4 indexed citations

11.

Hageman, Steven H J, Jannick A N Dorresteijn, Michiel L. Bots, et al.. (2021). Residual cardiovascular risk reduction guided by lifetime benefit estimation in patients with symptomatic atherosclerotic disease: effectiveness and cost-effectiveness. European Journal of Preventive Cardiology. 29(4). 635–644. 1 indexed citations

12.

Burger, P.M., et al.. (2020). Outcomes of second opinions in general internal medicine. PLoS ONE. 15(7). e0236048–e0236048. 8 indexed citations

13.

Vries, Marieke de, Jan Westerink, Karin Kaasjager, & Harold W. de Valk. (2020). Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) in Patients With Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis. The Journal of Clinical Endocrinology & Metabolism. 105(12). 3842–3853. 95 indexed citations

14.

Zwakenberg, Sabine R., Pim A. de Jong, Jonas W. Bartstra, et al.. (2019). The effect of menaquinone-7 supplementation on vascular calcification in patients with diabetes: a randomized, double-blind, placebo-controlled trial. American Journal of Clinical Nutrition. 110(4). 883–890. 57 indexed citations

15.

Immink, Rogier V., Jean-Paul P.M. de Vries, Raechel J. Toorop, et al.. (2019). Transcranial Doppler 24 Hours after Carotid Endarterectomy Accurately Identifies Patients Not at Risk of Cerebral Hyperperfusion Syndrome. European Journal of Vascular and Endovascular Surgery. 58(3). 320–327. 14 indexed citations

16.

Postmus, Douwe, et al.. (2018). The early economic evaluation of novel biomarkers to accelerate their translation into clinical applications. Cost Effectiveness and Resource Allocation. 16(1). 23–23. 6 indexed citations

17.

Vorselaars, Wessel M.C.M., Gerlof D. Valk, Menno R. Vriens, Jan Westerink, & Wilko Spiering. (2018). Case detection in primary aldosteronism. Journal of Hypertension. 36(7). 1585–1591. 10 indexed citations

18.

Jong, Marit de, H. Bart van der Worp, Yolanda van der Graaf, Frank L.J. Visseren, & Jan Westerink. (2017). Pioglitazone and the secondary prevention of cardiovascular disease. A meta-analysis of randomized-controlled trials. Cardiovascular Diabetology. 16(1). 134–134. 94 indexed citations

19.

Westerink, Jan, Yolanda van der Graaf, L. Jaap Kappelle, et al.. (2017). Risk Factors for Recurrent Cardiovascular Events Before Age 65 Years or Within 2.5 Years of a Recent First Cardiovascular Event. The American Journal of Cardiology. 120(2). 167–173. 1 indexed citations

20.

Faber, Daniel, Eric Kalkhoven, Jan Westerink, et al.. (2012). Conditioned media from (pre)adipocytes stimulate fibrinogen and PAI-1 production by HepG2 hepatoma cells. Nutrition and Diabetes. 2(12). e52–e52. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact